Simplex Trading
CGEM icon

Simplex Trading’s Cullinan Oncology CGEM Stock Holding History

Simplex Trading’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
17,444
-187
-1% -$2.78K ﹤0.01% 4159
2026
Q1 		$251K Buy
17,631
+4,378
+33% +$56.3K ﹤0.01% 4033
2025
Q4 		$137K Sell
13,253
-32
-0.2% -$289 ﹤0.01% 4640
2025
Q3 		$78K Sell
13,285
-6,272
-32% -$45.9K ﹤0.01% 6019
2025
Q2 		$147K Buy
19,557
+15,959
+444% +$128K ﹤0.01% 4821
2025
Q1 		$27K Buy
3,598
+2,195
+156% +$21.1K ﹤0.01% 6326
2024
Q4 		$17K Sell
1,403
-6,220
-82% -$89.4K ﹤0.01% 6797
2024
Q3 		$127K Buy
+7,623
New +$135K ﹤0.01% 4975
2024
Q2 		– Sell
-119
Closed -$2.53K – 8872
2024
Q1 		$2K Sell
119
-392
-77% -$6.06K ﹤0.01% 8372
2023
Q4 		$5K Sell
511
-530
-51% -$4.7K ﹤0.01% 7830
2023
Q3 		$9K Sell
1,041
-242
-19% -$2.52K ﹤0.01% 7229
2023
Q2 		$13K Buy
+1,283
New +$13.6K ﹤0.01% 7145
2022
Q3 		– Sell
-289
Closed -$3.89K – 9972
2022
Q2 		$3K Buy
+289
New +$3.28K ﹤0.01% 9114

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's CGEM Position: Q2 2026 in Review

Simplex Trading reduced its Cullinan Oncology (CGEM) stake by 1.1% in Q2 2026, selling an estimated $2.78K and leaving 17,444 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Simplex Trading first reported a position in CGEM in Q2 2022 and has held it in 13 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Simplex Trading held 17,444 shares of Cullinan Oncology worth $318K as of Q2 2026.
  • Simplex Trading sold 187 Cullinan Oncology shares in Q2 2026, an estimated $2.78K.
  • Cullinan Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4159 holding.
  • Simplex Trading first reported a position in Cullinan Oncology in Q2 2022 and has held it in 13 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.